Editorial: Cancer testis antigens in cancer: Recent developments as cancer biomarkers and therapeutic targets
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.1075329/full |
_version_ | 1817975989953626112 |
---|---|
author | Adviti Naik Joe Yeong Joe Yeong Julie Decock Julie Decock |
author_facet | Adviti Naik Joe Yeong Joe Yeong Julie Decock Julie Decock |
author_sort | Adviti Naik |
collection | DOAJ |
first_indexed | 2024-04-13T21:57:38Z |
format | Article |
id | doaj.art-aaa1527012c0448f842cb46b41b304b8 |
institution | Directory Open Access Journal |
issn | 2234-943X |
language | English |
last_indexed | 2024-04-13T21:57:38Z |
publishDate | 2022-11-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Oncology |
spelling | doaj.art-aaa1527012c0448f842cb46b41b304b82022-12-22T02:28:13ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-11-011210.3389/fonc.2022.10753291075329Editorial: Cancer testis antigens in cancer: Recent developments as cancer biomarkers and therapeutic targetsAdviti Naik0Joe Yeong1Joe Yeong2Julie Decock3Julie Decock4Translational Cancer and Immunity Center, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), Doha, QatarInstitute of Molecular and Cell Biology (ASTAR), Singapore, SingaporeDivision of pathology, Singapore General Hospital, Singapore, SingaporeTranslational Cancer and Immunity Center, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), Doha, QatarCollege of Health and Life Sciences (CHLS), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), Doha, Qatarhttps://www.frontiersin.org/articles/10.3389/fonc.2022.1075329/fullcancer testis antigencancer biologycancer biomarkercancer therapyimmunotherapy |
spellingShingle | Adviti Naik Joe Yeong Joe Yeong Julie Decock Julie Decock Editorial: Cancer testis antigens in cancer: Recent developments as cancer biomarkers and therapeutic targets Frontiers in Oncology cancer testis antigen cancer biology cancer biomarker cancer therapy immunotherapy |
title | Editorial: Cancer testis antigens in cancer: Recent developments as cancer biomarkers and therapeutic targets |
title_full | Editorial: Cancer testis antigens in cancer: Recent developments as cancer biomarkers and therapeutic targets |
title_fullStr | Editorial: Cancer testis antigens in cancer: Recent developments as cancer biomarkers and therapeutic targets |
title_full_unstemmed | Editorial: Cancer testis antigens in cancer: Recent developments as cancer biomarkers and therapeutic targets |
title_short | Editorial: Cancer testis antigens in cancer: Recent developments as cancer biomarkers and therapeutic targets |
title_sort | editorial cancer testis antigens in cancer recent developments as cancer biomarkers and therapeutic targets |
topic | cancer testis antigen cancer biology cancer biomarker cancer therapy immunotherapy |
url | https://www.frontiersin.org/articles/10.3389/fonc.2022.1075329/full |
work_keys_str_mv | AT advitinaik editorialcancertestisantigensincancerrecentdevelopmentsascancerbiomarkersandtherapeutictargets AT joeyeong editorialcancertestisantigensincancerrecentdevelopmentsascancerbiomarkersandtherapeutictargets AT joeyeong editorialcancertestisantigensincancerrecentdevelopmentsascancerbiomarkersandtherapeutictargets AT juliedecock editorialcancertestisantigensincancerrecentdevelopmentsascancerbiomarkersandtherapeutictargets AT juliedecock editorialcancertestisantigensincancerrecentdevelopmentsascancerbiomarkersandtherapeutictargets |